Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-24-000835)

Filing Details

Accession Number:: 0001127602-24-000835
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-01-04 16:36:11
Reporting Period:: 2024-01-04

Accepted Time:: 2024-01-04 16:36:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1061983	Cytokinetics Inc	CYTK	Pharmaceutical Preparations (2834)	943291317

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1551778	Ibraham Fady Malik	350 Oyster Point Blvd South San Francisco CA 94080	Evp Research & Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-01-04	11,678	$7.96	162,651	No	4	M	Direct
Common Stock	Disposition	2024-01-04	11,678	$86.98	150,973	No	4	S	Direct
Common Stock	Disposition	2024-01-04	4,000	$86.99	146,973	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (Right to Buy)	Disposition	2024-01-04	11,678	$0.00	11,678	$7.96

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2015-03-26	2025-02-26	No	4	M	Direct

Footnotes

Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.